Now livetag icon
AI created more apps than ever, but 75% won't make it. Find out how to win. Download the reportbanner icon
Diatex

May 2026

Diatex Market Share Analysis for May 2026

パイオランテープ(養生テープ)の最大幅やドレンド、スリット加工を動画で紹介しているコラム記事です。
Year Founded--
Employees201 - 500
Annual Revenue--
diatex.com
Diatex
Diatex (including company regionals)
  • diatex.com
    diatex.com
See more website traffic and engagement information

Total visits to Diatex's top domains

Understand Diatex market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Diatex's top domains

Analyze Diatex engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Diatex's top domains

See how Diatex keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Diatex

These are the website technologies, by industry, used by Diatex top domains

Widget (5)

Twemoji

Twemoji

Advertising (3)

Google Adsense

Google Adsense

Email Services (3)

Microsoft Exchange Online

Microsoft Exchange Online

Conversion & Analytics (2)

Google Analytics

Google Analytics

More Technologies

7

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Diatex

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDiatex Sas is developing therapeutic products comrprising halofenate.It has development and licensing agreement with Janssen Pharmaceuticals, Inc. to develop and discover undisclosed metabolic disease target agonists for the treatment of type II diabetes and other disorders; and a license agreement with DiaTex, Inc. to develop and commercialize therapeutic products comrprising halofenate and its enantiomers, derivatives, and analogs for the treatment of diseases.
NewsDiatex Sas is developing therapeutic products comrprising halofenate.It has development and licensing agreement with Janssen Pharmaceuticals, Inc. to develop and discover undisclosed metabolic disease target agonists for the treatment of type II diabetes and other disorders; and a license agreement with DiaTex, Inc. to develop and commercialize therapeutic products comrprising halofenate and its enantiomers, derivatives, and analogs for the treatment of diseases.

See all Diatex signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.